Sign up to save your podcasts
Or
Share New CDK4/6i Data Move Metastatic Breast Cancer Field Forward
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New CDK4/6i Data Move Metastatic Breast Cancer Field Forward
At ASCO 2017, the MONARCH-3, PALOMA-1, AND TREnd trials shed light on the efficacy of new CDK4/6 inhibitors for metastatic breast cancer.
View all episodes
By MedscapeAt ASCO 2017, the MONARCH-3, PALOMA-1, AND TREnd trials shed light on the efficacy of new CDK4/6 inhibitors for metastatic breast cancer.